Monday, Macquarie initiated coverage on Healthcare Services Group (NASDAQ:HCSG) with a Neutral rating and a price target of $13.00. The firm recognized HCSG's extensive experience and scale in providing non-clinical services to long-term care facilities.
According to InvestingPro analysis, the stock appears undervalued at current levels, trading at an attractive PEG ratio of 0.26. Despite a history of consistent earnings growth and regular dividend increases, the company has faced challenges due to financial distress among some clients, which has impacted revenue collection.
The pandemic added to these pressures, resulting in a lower facility census, staffing shortages, and increased food and labor costs. While HCSG has made contract adjustments and client restructurings to improve operating margins, these changes have come at the cost of growth.
InvestingPro data shows current gross profit margins at 14.35%, reflecting these operational challenges. Additionally, the suspension of dividends has led to a decrease in the company's valuation multiple, which now stands at a 15x forward P/E multiple compared to its historical average of 27x since 2010.
Macquarie noted that HCSG's existing business is showing signs of improvement as long-term care facilities begin to increase their census, labor conditions stabilize, and inflation levels out. However, the firm also pointed out that uncertainties surrounding the company's growth prospects are likely to cap any potential valuation recovery in the near term.
The report further commented on HCSG's financial leverage, describing it as modest. Nevertheless, Macquarie suggested that the company would need to strengthen its balance sheet further before it can consider reinstating its previously consistent dividend payouts.
In other recent news, Healthcare Services Group, Inc. (HCSG) revealed strong financial results for Q3 of 2024. The company reported a revenue of $428.1 million, net income of $14 million, and a diluted EPS of $0.19. Occupancy rates climbed to 79.8%, and the workforce expanded by over 100,000 jobs since early 2023.
The firm's Q4 revenue is projected between $430 million and $440 million, and the year's adjusted cash flow from operations target is reaffirmed at $40 million to $55 million.
HCSG has also repurchased over 350,000 shares in 2024, with authorization for an additional 6.1 million shares. The company is optimistic about future growth, anticipating further expansion in the environmental services and education sectors. Analysts from the firm have identified opportunities in high acuity assisted living and behavioral health centers.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.